SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $97,000 | -19.2% | 12,701 | +2.7% | 0.01% | -16.7% |
| Q2 2021 | $120,000 | +118.2% | 12,366 | +87.6% | 0.01% | +100.0% |
| Q1 2021 | $55,000 | -38.9% | 6,590 | -17.9% | 0.00% | -50.0% |
| Q3 2020 | $90,000 | +95.7% | 8,031 | +8.7% | 0.01% | +100.0% |
| Q2 2020 | $46,000 | +4500.0% | 7,385 | +1085.4% | 0.00% | – |
| Q1 2020 | $1,000 | -75.0% | 623 | -20.1% | 0.00% | – |
| Q1 2019 | $4,000 | -76.5% | 780 | -80.8% | 0.00% | -100.0% |
| Q3 2018 | $17,000 | +1600.0% | 4,063 | +1722.0% | 0.00% | – |
| Q1 2018 | $1,000 | -80.0% | 223 | -82.9% | 0.00% | – |
| Q4 2017 | $5,000 | +66.7% | 1,307 | -31.8% | 0.00% | – |
| Q3 2017 | $3,000 | +50.0% | 1,917 | +120.9% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 868 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 868 | +7.7% | 0.00% | – |
| Q4 2016 | $4,000 | – | 806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
| B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
| EMFO, LLC | 209,398 | $185,527 | 0.19% |
| Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
| Mayo Clinic | 300,000 | $267,000 | 0.14% |
| swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
| Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
| Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
| EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
| Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |